Three years into the Covid-19 pandemic, it is clear that some of us produce stronger immune reactions to infection than others. Some may only experience mild flu-like symptoms, while others could be ...

Artificial intelligence (AI) and machine learning (ML) are having a significant impact on how the biopharma industry develops new therapeutic antibodies. What historically has been a slow, ...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent for Coronavirus Disease 2019 (COVID-19), emerged in late December 2019, leading to the ongoing worldwide pandemic.

Researchers have found that the flexibility of the structure between the arms of an antibody—the so-called “hinge”—influences the strength of the immune response that it elicits. This finding could be ...

Antibodies are immune proteins that our bodies produce to help fight off infection. Where they recognize and bind a pathogen — and how — can give important clues to the microbe’s vulnerabilities. Fred ...

The history of antibody engineering and production in drug discovery can be traced back to the 1970s and 1980s [1] when scientists first began to explore the potential of using antibodies as ...

The coronavirus disease 2019 (COVID-19) pandemic has caused more than 223 million cases, of whom over 4.78 million have been fatal. Vaccination has been very patchy, leading to the emergence of new ...

MOG antibody-associated disease (MOGAD) is a rare autoimmune disease of the central nervous system. The blood of patients ...